Eichenfield LF, Stein Gold LF, Simpson EL, Zaenglein AL, et al. Efficacy and Safety of Ruxolitinib Cream in Children Aged 2 to 11 Years With Atopic Dermatitis: Results From TRuE-AD3, a Phase 3, Randomized Double-Blind Study. J Am Acad Dermatol 2025 May 14:S0190-9622(25)02124.
PMID: 40378883